Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.

× No keyword cloud information.

8 in total

1. Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors: N Callagham; M Mcllroy; M O'Connor
Journal: Ir J Med Sci Date: 1974-03 Impact factor: 1.568

2. Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors: J R Bianchine; L Sunyapridakul
Journal: Drugs Date: 1973 Impact factor: 9.546

3. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors: J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal: J Neurol Neurosurg Psychiatry Date: 1974-04 Impact factor: 10.154

4. Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study.

Authors: A Barbeau; H Mars; M I Botez; M Joubert
Journal: Can Med Assoc J Date: 1971-07-10 Impact factor: 8.262

5. Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.

Authors: George DeMaagd; Ashok Philip
Journal: P T Date: 2015-10

Review 6. The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.

Authors: Si Shen; Chan Zhang; Yu-Ming Xu; Chang-He Shi
Journal: J Parkinsons Dis Date: 2022 Impact factor: 5.568

Review 7. Amantadine in Parkinson's disease.

Authors: N Crosby; K H Deane; C E Clarke
Journal: Cochrane Database Syst Rev Date: 2003

Review 8. NMDA antagonists for treating the non-motor symptoms in Parkinson's disease.

Authors: Brigitte Vanle; William Olcott; Jaime Jimenez; Luma Bashmi; Itai Danovitch; Waguih William IsHak
Journal: Transl Psychiatry Date: 2018-06-15 Impact factor: 6.222

8 in total